Chronic Obstructive Pulmonary Disease Market to 2019: Global Industry Analysis, Size, Trends Research Report Highly-Priced New Combination Products Forecast to Capture Significant Market and Drive Growth

• A disease introduction, which defines the disease, including symptoms, diagnosis and treatment.
• An analysis of the COPD marketed landscape, including a comparison of the efficacy and safety of the most prominent brands, displayed as a heat map.
• A detailed analysis of the COPD pipeline, detailing, among other parameters, drug distribution by phase, molecule type and mechanism of action. The COPD clinical trial landscape is then analysed, with a particular emphasis on failure rates across phases as well as the trends in clinical trial size and duration and by mechanism of action.
• An in-depth forecasting model for the COPD market, which considers the current marketed therapies, in addition to the potential market entry of new products. The model consists of a projected outcome, with high and low variance results, depending on the potential performance of pipeline therapies. This takes into account worst and best case scenarios for market uptake, costs and patent expirations.
• Strategic consolidations within the COPD indication are analyzed, which includes co-development and licensing agreements.
• An overview of the drivers and barriers for the COPD market is also included.

Buy a copy of this report@ http://www.researchmoz.us/sample/checkout.php?rep_id=168797&type=S

• Primarily, the report will allow clients to gain a strong understanding of the COPD indication, helping to identify and understand market opportunities and the emerging competitive environment. It will also allow you to:
• Understand the COPD pipeline and the factors which indicate that it is becoming more innovative as well as the key pipeline molecules that look set to have a big impact upon the COPD market.
• Observe detailed profiles for the promising pipeline products and gain insights into how they are likely to compete in the market, and what their main competitors will be.
• Follow the trends in COPD clinical trial size and duration in relation to industry averages. In addition, the report will enable you to assess the potential risk of future developmental programs for COPD therapeutics, depending on the mechanism of action, by considering the recorded clinical trial failure rates.
• Observe the potential growth patterns expected for the COPD market over the forecast period, and identify which countries are expected to contribute most to this growth.

#####

Related Reports

Transcatheter Heart Valve Market to 2017 (http://www.researchmoz.us/transcatheter-heart-valve-market-to-2017-approval-of-second-generation-prosthetics-and-increasing-surgeons-confidence-and-proficiency-to-drive-tavr-procedure-volumes-report.html) – Improving Surgeons’ Confidence and Proficiency to Drive Growth of Routes of Access Other than Transfemoral” report examines the market, competitive landscape, and trends for the Transcatheter Heart Valves (THVs) market. The report provides comprehensive information on the key trends affecting these segments, and key analytical content related to market dynamics. The report also reviews the competitive landscape and provides a detailed analysis of the pipeline products for each segment, as well as details of important Mergers and Acquisitions (M&A) deals. The report has been compiled using data and information sourced from proprietary databases, primary and secondary research and in-house analysis carried out by GBI Research’s team of industry experts.